Breast cancer in Mexico: a growing challenge to health and the health system
- PMID: 22846838
- DOI: 10.1016/S1470-2045(12)70246-2
Breast cancer in Mexico: a growing challenge to health and the health system
Abstract
Breast cancer is a major public health issue in low-income and middle-income countries. In Mexico, incidence and mortality of breast cancer have risen in the past few decades. Changes in health-care policies in Mexico have incorporated programmes for access to early diagnosis and treatment of this disease. This Review outlines the status of breast cancer in Mexico, regarding demographics, access to care, and strategies to improve clinical outcomes. We identify factors that contribute to the existing disease burden, such as low mammography coverage, poor quality control, limited access to diagnosis and treatment, and insufficient physical and human resources for clinical care.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
A quest for quality and economic effectiveness throughout the continuum of breast care.Breast. 2010 Aug;19(4):251-2. doi: 10.1016/j.breast.2010.03.020. Epub 2010 Apr 13. Breast. 2010. PMID: 20392641 No abstract available.
-
Breast cancer in limited-resource countries: early detection and access to care.Breast J. 2006 Jan-Feb;12 Suppl 1:S16-26. doi: 10.1111/j.1075-122X.2006.00200.x. Breast J. 2006. PMID: 16430395
-
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.Breast J. 2006 Jan-Feb;12 Suppl 1:S3-15. doi: 10.1111/j.1075-122X.2006.00199.x. Breast J. 2006. PMID: 16430397
-
Mammographic screening for breast cancer: An invited review of the benefits and costs.Breast. 2010 Aug;19(4):268-72. doi: 10.1016/j.breast.2010.03.017. Epub 2010 Apr 3. Breast. 2010. PMID: 20371181 Review.
-
Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness.Breast. 2010 Aug;19(4):260-7. doi: 10.1016/j.breast.2010.03.013. Breast. 2010. PMID: 20399656 Review.
Cited by
-
Psychological suppressive profile and autoantibodies variability in women living with breast cancer: A prospective cross-sectional study.Heliyon. 2022 Oct 7;8(10):e10883. doi: 10.1016/j.heliyon.2022.e10883. eCollection 2022 Oct. Heliyon. 2022. PMID: 36237972 Free PMC article.
-
Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.PLoS One. 2015 Sep 1;10(9):e0134618. doi: 10.1371/journal.pone.0134618. eCollection 2015. PLoS One. 2015. PMID: 26325181 Free PMC article. Review.
-
High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells.Cell Oncol (Dordr). 2016 Aug;39(4):365-78. doi: 10.1007/s13402-016-0282-8. Epub 2016 Apr 22. Cell Oncol (Dordr). 2016. PMID: 27106722
-
The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.Breast Cancer Res Treat. 2015 Apr;150(2):389-94. doi: 10.1007/s10549-015-3312-8. Epub 2015 Feb 26. Breast Cancer Res Treat. 2015. PMID: 25716084 Free PMC article.
-
ESR2 gene variants (rs1256049, rs4986938, and rs1256030) and their association with breast cancer risk.PeerJ. 2022 May 10;10:e13379. doi: 10.7717/peerj.13379. eCollection 2022. PeerJ. 2022. PMID: 35573183 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous